Company
FogPharma
Advancing a new class of ultra-tunable peptide therapeutics to unlock historically undruggable targets and achieve extraordinary outcomes for people affected by serious diseases.
Also known as Parabilis Medicines
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Parabilis Medicines
- fogpharma.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Based on our ultra-tunable Helicon™ peptide platform, the novel medicines we’re advancing represent that rarest of opportunities: a chance to fundamentally change treatment possibilities for cancer and other diseases with critical need.
Products
- Other
- Helicon peptide platform
Loading relationship preview